May 7, 2018 / 11:08 AM / 2 months ago

BRIEF-Aptose Biosciences Says Exercises Early Option For Cg-806 License From Crystalgenomics

May 7 (Reuters) - Crystal Genomics Inc:

* APTOSE BIOSCIENCES INC - EXERCISES EARLY OPTION FOR CG-806 LICENSE FROM CRYSTALGENOMICS

* APTOSE BIOSCIENCES INC - CO OWNS GLOBAL RIGHTS TO DEVELOP AND COMMERCIALIZE CG-806 FOR ALL INDICATIONS OUTSIDE OF KOREA AND CHINA - LICENSED TERRITORY

* APTOSE BIOSCIENCES- CRYSTALGENOMICS ELIGIBLE FOR REGULATORY AND SALES MILESTONE PAYMENTS, AS WELL AS ROYALTIES ON PRODUCT SALES IN LICENSED TERRITORY

* APTOSE BIOSCIENCES INC - OPTION EXERCISE TRIGGERS A PAYMENT OF US $2.0 MILLION TO CRYSTALGENOMICS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below